logo
logo

Specific Biologics Closes Seed Financing With Industry Leaders Lumira Ventures And Admare Bioinnovations

Dec 16, 2021•over 3 years ago

Round Type

seed

Toronto

Description

Specific Biologics Inc. ("Specific") today announced that it has closed its first institutional financing, led by Lumira Ventures and adMare BioInnovations which have recently established an innovative partnership to build Canadian life sciences companies.

Company Information

Company

Specific Biologics

Location

Toronto, Ontario, Canada

About

Specific Biologics Inc. ("Specific") is a venture-backed early-stage biotechnology company on a mission to develop novel gene editing technologies to treat diseases through precision gene editing. Our two-site DualaseTM platform gene editors cut DNA in a way that optimally exploits the cell's naturally occurring DNA repair pathways. This enables two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of DualaseTM-based therapeutics in areas of high unmet medical need. To learn more, visit www.specificbiologics.com.